2012 Midyear Clinical Meeting
Click here to go to the previous page
First Do No Harm: Prevention, Detection & Management of Drug-Induced Diseases
Track:
Education Sessions (CE)
Program Code: 222-L01
Date: Tuesday, December 4, 2012
Time: 8:00 AM to 10:00 AM EST
Location:
Mandalay Bay F, Level 2, South Convention Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
|
Douglas A. Miller, Pharm.D. is a professor at the Wayne State University College of Pharmacy and Health Sciences in Detroit, and teaches courses dealing with professional practice and patient care. He earned his BS in Pharmacy from the Ohio State University College of Pharmacy in 1972 and his doctorate from the Philadelphia College of Pharmacy in 1976. His pharmacy experience includes practice in community, long term care and hospital settings. For more than 20 years, he led a team that conceptualized and implemented innovative clinical pharmacy services at Detroits Henry Ford Hospital.
Miller served as a member of the Michigan Board of Pharmacy for 11 years including two terms as board chair. He has also served as a member of the Board of Trustees of the American Pharmacists Association (APhA) and the boards of both the Michigan Pharmacists Association and the Michigan Society of Health-System Pharmacists. He is the recipient of several awards and honors including distinguished alumni awards from the Ohio State University College of Pharmacy and the Philadelphia College of Pharmacy, the Pharmacist of the Year Award of the Michigan Pharmacists Association, and awards from both the American Society of Health-System Pharmacists and the APhA for outstanding practice in hospital pharmacy. He is a fellow of the American Pharmacists Association and co-editor of a reference text entitled, Drug-Induced Diseases: Prevention, Detection and Management.
|
|
Dr. James Tisdale earned a BSc in pharmacy at the University of Manitoba in Winnipeg, Canada and a Doctor of Pharmacy at the State University of New York at Buffalo. He completed a pharmacy practice residency at the University of Manitoba Health Sciences Centre and a post-doctoral fellowship in Cardiovascular Therapeutics at Hartford Hospital and the University of Connecticut. From 1990-2002 he was an Assistant/Associate Professor at the College of Pharmacy and Health Sciences at Wayne State University in Detroit, MI, where his practice and clinical research site was Henry Ford Hospital. Currently, he is a Professor and Interim Head of the Department of Pharmacy Practice at Purdue University and Adjunct Professor in the Division of Clinical Pharmacology at the Indiana University School of Medicine.
Jim maintains an active research program in cardiovascular pharmacotherapy that centers on mechanisms, prevention and management of naturally occurring and drug-induced arrhythmias, and general medication safety. Jims research has resulted in the publication of more than 100 journal articles, book chapters and abstracts. Jim is the co-editor of the book entitled, Drug-Induced Diseases: Prevention, Detection and Management, which is published by ASHP and is in its second edition.
Jim has contributed a substantial amount of service to numerous professional organizations, and from 2009-2010 served as the President of the American College of Clinical Pharmacy.
|
PROGRAM CHAIR:
Click the plus sign to see more detailed information about each speaker.
|
Dr. James Tisdale earned a BSc in pharmacy at the University of Manitoba in Winnipeg, Canada and a Doctor of Pharmacy at the State University of New York at Buffalo. He completed a pharmacy practice residency at the University of Manitoba Health Sciences Centre and a post-doctoral fellowship in Cardiovascular Therapeutics at Hartford Hospital and the University of Connecticut. From 1990-2002 he was an Assistant/Associate Professor at the College of Pharmacy and Health Sciences at Wayne State University in Detroit, MI, where his practice and clinical research site was Henry Ford Hospital. Currently, he is a Professor and Interim Head of the Department of Pharmacy Practice at Purdue University and Adjunct Professor in the Division of Clinical Pharmacology at the Indiana University School of Medicine.
Jim maintains an active research program in cardiovascular pharmacotherapy that centers on mechanisms, prevention and management of naturally occurring and drug-induced arrhythmias, and general medication safety. Jims research has resulted in the publication of more than 100 journal articles, book chapters and abstracts. Jim is the co-editor of the book entitled, Drug-Induced Diseases: Prevention, Detection and Management, which is published by ASHP and is in its second edition.
Jim has contributed a substantial amount of service to numerous professional organizations, and from 2009-2010 served as the President of the American College of Clinical Pharmacy.
|
Description
Overview of Drug-Induced Diseases: Epidemiology, Public Health Impact, and Evidence That Pharmacists May Have an Impact on Prevention and Management, James E. Tisdale, PharmD, BCPS
Evaluating Your Patient for Drug-Induced Diseases, Douglas A. Miller, PharmD
Drug-Induced Diseases Interactive Case Discussions, James E. Tisdale, PharmD, BCPS; Douglas A. Miller, PharmD
- Evaluate evidence that pharmacists can improve patient health care outcomes by preventing and detecting drug-induced diseases.
- Identify common organ systems affected by drug-induced diseases.
- Identify major drug classes associated with drug-induced diseases.
- Improve participants' clinical skills in detecting and managing drug-induced diseases through interactive case examples and discussion.
